Healthy Extracts Inc. (OTCQB: HYEX) - Invited to present at the Trickle Research Microcap Conference on November 13, 2025
Overview
Healthy Extracts Inc. (OTCQB:HYEX), announced it has been invited to present at the Trickle Research Microcap Conference being held at Topgolf Centennial in Centennial, Colorado on November 13, 2025. The company is scheduled to present at 3:06 p.m. Mountain time, with a live stream available on the day of the event. The release highlights recent operating metrics and a merger that management says have accelerated the company’s growth outlook.
Key Highlights
- Presentation at Trickle Research Microcap Conference on November 13, 2025, scheduled for 3:06 p.m. Mountain time.
- Q3 2025 net revenue expected up more than 23 percent versus the same quarter last year.
- Direct-to-consumer product subscriptions up 58 percent year over year in Q3 2025.
- Amazon.com "Subscribe & Save" orders up 98 percent year over year in Q3 2025.
- Recent merger with Gummy USA completed at the beginning of October, which management states has accelerated the company’s growth outlook by more than 50 percent.
- Announced 6 million nutraceutical gummy follow-on order from a woman’s health nutraceutical leader.
- New proprietary, patent-pending SureDose gummy manufacturing technology for precision-dosed nutraceutical gummies.
- Maintained a top three category ranking on Amazon over the past year.
Strategic / Operational Context
Management plans to highlight a platform strategy to acquire, develop, and market nutraceutical products and technologies, supported by subscription-based recurring revenue and optimized sales and marketing. The Gummy USA merger adds manufacturing capabilities and complements other oral delivery technologies referenced in the release.
What to Watch Next
- Company presentation on November 13, 2025 at 3:06 p.m. Mountain time.
- Integration progress and revenue contribution following the Gummy USA merger, including fulfillment of the 6 million gummy follow-on order referenced in the release.
Commentary
The conference appearance provides investor visibility alongside disclosed growth metrics for Q3 2025. The Gummy USA merger and SureDose technology expand manufacturing and product capabilities, which the company states have improved its growth outlook. Execution on subscription growth and large follow-on orders will be key to sustaining the momentum described in the release.
About Healthy Extracts Inc.
Healthy Extracts Inc. develops, manufactures and markets proprietary, science-based supplements for brain, heart, and gut health, supported by clinically tested formulas and partnerships. Its Gummy USA subsidiary manufactures precision-dosed nutraceutical and pharmaceutical-grade gummies using patent-pending SureDose technology. Wholly owned subsidiaries BergametNA and Ultimate Brain Nutrients offer heart and brain health supplements, with additional exclusive agreements covering oral delivery systems such as Gelteq gel-packs and a Gut Health Straw.
ArcStone Financial Pulse Team
Stay informed with the latest market trends from ArcStone Securities and Investments Corp. Subscribe to our newsletter for more detailed reports and analysis.
Disclaimer and Forward-Looking Statements
The information contained herein is provided by ArcStone Securities and Investments Corp. (“ArcStone”) for informational purposes only. It is not, and under no circumstances should it be construed as, an offer to sell or a solicitation of an offer to buy any securities or other financial instruments in any jurisdiction.
Certain statements contained herein may constitute “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements are based on current expectations, estimates, and assumptions that involve known and unknown risks and uncertainties which may cause actual results or developments to differ materially from those expressed or implied. These statements often include words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “should,” “target,” or similar expressions. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Except as required by law, ArcStone undertakes no obligation to update or revise any forward-looking information.
This content is not intended as investment advice or a recommendation to buy or sell any security and does not take into account the investment objectives, financial situation, or needs of any individual. Investors should consult their own professional advisors before making any investment decisions.
ArcStone Securities and Investments Corp. is not a registered broker-dealer and does not provide investment advice or recommendations. All registrable activities in the United States are conducted through ArcStone Securities, LLC and Kingswood US, both FINRA-registered broker-dealers. In Canada, on a transaction-by-transaction basis, all registrable activities are conducted through Sentinel Financial Group, a registered Exempt Market Dealer (EMD) in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and the Northwest Territories.
The issuer featured in this article (the “Company”) is a current or recent client of ArcStone or one of its affiliates. ArcStone and/or its affiliates have received or expect to receive cash and/or equity compensation for the provision of corporate advisory, investor relations, digital media, or capital markets consulting services to the Company. This relationship represents a potential conflict of interest, as ArcStone may be perceived to have an incentive to present the Company in a favorable light. The principals, officers, directors, employees, and related entities of ArcStone and its affiliates may, from time to time, own, buy, or sell securities or derivatives of the Company or its affiliates.
